Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma

NCT03602833 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Soft-tissue Sarcoma

Interventions

DRUG: Compound 451238

Sponsor

Royal Marsden NHS Foundation Trust

Collaborators

[object Object]